SELLAS Life Sciences Group, Inc. Common Stock (SLS) Stock Price

SLSStock

$14.09+650.00%52W

Market Cap$2.85B

P/E—

PEG Ratio—

Div yield—

Beta2.57

SLS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)266.72%

Price vs S&P 500 (4W)38.92%

VGM Score51.45

Book Value / Share (Quarterly)$0.59

P/TBV (Annual)4.32x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.16

Price vs S&P 500 (YTD)268.01%

Gross Margin (TTM)93.10%

Net Profit Margin (TTM)-736.21%

EPS (TTM)$-0.23

10-Day Avg Trading Volume7.40M

EPS Excl Extra (TTM)$-0.23

EPS (Annual)$-0.51

ROI (Annual)-327.52%

Gross Margin (Annual)90.00%

Net Profit Margin (5Y Avg)-1197.32%

Cash / Share (Quarterly)$0.59

ROA (Last FY)-159.53%

EBITD / Share (TTM)$-0.24

ROE (5Y Avg)-331.50%

Operating Margin (TTM)-730.69%

Cash Flow / Share (Annual)$-0.19

P/B Ratio22.88x

P/B Ratio (Quarterly)7.07x

Net Income / Employee (Annual)$-2,384,600

EV / Revenue (TTM)810.58x

Net Interest Coverage (TTM)-238.57x

ROA (TTM)-42.63%

EPS Incl Extra (Annual)$-0.51

Current Ratio (Annual)10.72x

Quick Ratio (Quarterly)16.60x

3-Month Avg Trading Volume8.49M

52-Week Price Return650.00%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.28

P/S Ratio (Annual)2457.78x

Asset Turnover (Annual)0.05x

52-Week High$15.88

Operating Margin (5Y Avg)-1281.81%

EPS Excl Extra (Annual)$-0.51

Tangible BV CAGR (5Y)52.96%

26-Week Price Return277.97%

Quick Ratio (Annual)10.28x

13-Week Price Return89.48%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)17.22x

Enterprise Value$2.35B

Asset Turnover (TTM)0.09x

Book Value / Share Growth (5Y)-17.33%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-4130.00%

Cash / Share (Annual)$0.47

3-Month Return Std Dev117.49%

Net Income / Employee (TTM)$-2,265,900

ROE (Last FY)-327.52%

Net Interest Coverage (Annual)-532.75x

EPS Basic Excl Extra (Annual)$-0.51

Receivables Turnover (TTM)4.46x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.23

Receivables Turnover (Annual)13.45x

ROI (TTM)-47.12%

P/S Ratio (TTM)847.51x

Pretax Margin (5Y Avg)-1213.64%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.28

Price vs S&P 500 (52W)631.69%

Year-to-Date Return279.97%

5-Day Price Return9.35%

EPS Normalized (Annual)$-0.51

ROA (5Y Avg)-214.47%

Net Profit Margin (Annual)-4130.00%

Month-to-Date Return43.11%

Cash Flow / Share (TTM)$-0.36

EBITD / Share (Annual)$-0.52

Operating Margin (Annual)-4195.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-331.50%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.23

P/TBV (Quarterly)4.31x

P/B Ratio (Annual)7.58x

Pretax Margin (TTM)-736.21%

Book Value / Share (Annual)$0.46

Price vs S&P 500 (13W)86.69%

Beta2.57x

Revenue / Share (TTM)$0.00

ROE (TTM)-47.12%

52-Week Low$1.39

vGradeF

mGradeA

vgmGradeC

SLS Earnings Surprise History

Q2 25-0.07est. -0.08

Q3 25-0.06est. -0.08

Q4 25-0.05est. -0.06

Q2 26-0.05est. -0.04

SLS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
SLSSELLAS Life Sciences Group, Inc. Common Stock	F	—	A	$14.09
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About SELLAS Life Sciences Group, Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing immunotherapies and targeted cancer treatments. The company's pipeline includes galinpepimut-S, a peptide immunotherapy targeting the WT1 antigen, and GFH009, a selective CDK9 inhibitor. Both candidates address multiple cancer indications through distinct mechanisms of action.